Outcome of renal transplantation from older living donors compared to younger living donor in developing country

Objectives: To evaluate whether the outcomes of renal grafts from living related donors older than 60 years are acceptable, in terms of renal function and patient/graft survival. Material and methods: One hundred and forty-seven patients who received kidneys from donor age ≥60 years constituted the study group (group 1). The control group (group 2) consisted of 1310 patients who received renal transplants from donor age <60 years. Outcome measures included graft, patient survival, acute rejection rate and serum creatinine (SCr) in patients/donors. Graft and patient survivals were compared using the Kaplan–Meier method. Results: The mean age of donors was 62.7?±?3.39 years in group 1 and 43.45?±?9.65 years in group 2. Patient survival at 1, 3 and 5 years was 95.7%, 89.4% and 82.6% in group 1 and 93.8%, 89.1% and 83.1% in group 2 (p?=?0.785), respectively. Death-censored graft survival at 1, 3 and 5 years was 98.5%, 94.8% and 94.8% in group 1 and 96.1%, 92.9% and 89% in group 2 (p?=?0.166), respectively. Biopsy-proven acute rejections were 21% and 16.8% (p?=?0.206) and chronic rejections 5% and 3.4% in group 1 and 2, respectively (p?=?0.542). Recipient SCr (mg/dL) was 1.8?±?0.31 in group 1 and 1.58?±?0.37 in group 2. The donor SCr levels at the last follow-up were 1?mg/dL and 0.9?mg/dL in group 1 and 2, respectively. Conclusions: Donor age did not affect patient and graft survival in the 5-year follow-up in our study. Age alone seems not to be an exclusion criterion to living kidney donation.